Preview

City Healthcare

Advanced search

Risk Assessment of Glaucoma in the Kyrgyz Republic

https://doi.org/10.47619/2713-2617.zm.2025.v.6i1;66-75

Abstract

Background. Glaucoma is the most common cause of irreversible blindness. Knowledge of the risk factors that cause the development of glaucoma is extremely important for the early detection of disease.

Purpose. To assess the risk factors for glaucoma.

Materials and methods. The study was conducted using a questionnaire survey among 318 patients who sought medical care at the Department of Eye Microsurgery No. 2 of the Bishkek National Hospital. 49.0% of respondents were men and 51.0% were women; the percent of respondents aged over 40 years was 41.8±2.7 among men and 44.6±2.7 among women. Statistical methods, such as the calculation of intensive value, biases in representativeness and reliability criteria, were applied. A multifactorial analysis was carried out to assess the share of influence of risk factors. The risk of developing glaucoma was estimated in points (from 30 to 40 — low, from 50 to 70 points — average, over 70 points — high). The prognostic significance of risk factors in men and women was calculated.

Results. The study showed a high risk of glaucoma in both men and women. In men, hereditary predisposition takes the first place in the development of glaucoma; the share of influence was 60.8%. In women, this risk factor is also the leading one, accounting for 67.2%. The second largest share of influence is high blood pressure in men (R=53.3%) and pre-existing diabetes mellitus (R=60.8%) in women. The age over 40 years is in the third place for men and women (R=50.4% and 54.7%, respectively). Diabetes mellitus is also one of the leading risk factors for glaucoma: 47.6% in men and 49.0% in women.

Conclusion. The factor analysis allowed us to identify the main risk factors for glaucoma. The identification of risk factors contributes to the early diagnosis and detection of the clinical and functional features of glaucoma, as well as to the timely treatment that reduces the complications of glaucoma. To reduce the risk of glaucoma, it is necessary to improve the high-quality medical care at all levels of the treatment and diagnostic process and to optimize measures aimed at reducing the prevalence of glaucoma and the impact of individual risk factors.

About the Authors

O. A. Bolbachan
Interstate educational organization of higher education First President of Russia Boris Yeltsin Kyrgyz-Russian Slavic University
Kyrgyzstan

Olga A. Bolbachan – Cand. Sci. in Medicine, Associate Professor 

44, Kievskaya ul., 720000, Bishkek



G. K. Omorova
International Higher School of Medicine
Kyrgyzstan

Guluzad K. Omorova – Doctoral Student, 

1F, Intergelpo ul., 720054, Bishkek



K. N. Bolbachan
Federal Medical-Biological Agency of the Russian Federation
Russian Federation

Kirill N. Bolbachan – ophthalmologist 

30, Volokolamskoye Shosse, 123182, Moscow



References

1. Flaxman S.R., Bourne RR.A., Resnikoff S., Ackland P., Braithwaite T., et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e1234. https://doi.org/10.1016/S2214-109X(17)30393-5

2. Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye (Lond). 2024;38(11):2036-2046. https://doi.org/10.1038/s41433-024-02995-5

3. Bhartiya S., Ichhpujani P., Wadhwani M. Current perspectives in tackling glaucoma blindness. Indian J Ophthalmol. 2025;73(Suppl 2):S189-S196. https://doi.org/10.4103/IJO.IJO_3280_23

4. Lev I.V., Gurko T.S. Cerebral and somatic risk factors in the development of glaucoma and diabetic retinopathy in the elderly. Scientific Journal Current Problems of Health Care and Medical Statistics. 2021;4:171-181. https://doi.org/10.24412/2312-2935-2021-4-171-181 (In Russ.)

5. Dorofeev D.A. Risk factors for glaucoma progression. Bulletin of the Council of Young Scientists and Specialists of the Chelyabinsk Region. 2014;1-2:29-35. (In Russ.)

6. Leske M.C. Open-angle glaucoma: an epidemiologic overview. Ophthalmic Epidemiol. 2007;14(4):166-172. https://doi.org/10.1080/09286580701501931

7. McMonnies C.W. Glaucoma history and risk factors. J Optom. 2017;10(2):71-78. https://doi.org/10.1016/j.optom.2016.02.003

8. Omorova G.K. The age and gender prevalence of concomitant eye diseases in open-angle glaucoma. Bulletin of Science and Practice. 2022;8(11):331-338. https://doi.org/10.33619/2414-2948/84/40 (In Russ.)

9. Horned NW. The prevalence of glaucoma in elderly patients. Regional Bulletin. 2019;23(38):17-18. (In Russ.)

10. Douglass A., Dattilo M., Feola A.J. Evidence for menopause as a sex-specific risk factor for glaucoma. Cell Mol Neurobiol. 2023;43(1):79-97. https://doi.org/10.1007/s10571-021-01179-z

11. Stein J.D., Khawaja A.P., Weizer J.S. Glaucoma in adults: screening, diagnosis, and management: a review. JAMA. 2021;325(2):164-174. https://doi.org/10.1001/jama.2020.21899

12. Tribble J.R., Hui F., Quintero H., El Hajji S., Bell K., Di Polo A., Williams P.A. Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering. Mol Aspects Med. 2023;92:101193. https://doi.org/10.1016/j.mam.2023.101193

13. Killer H.E., Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye (Lond). 2018;32(5):924-930. https://doi.org/10.1038/s41433-018-0042-2

14. Chen S.J., Lu P., Zhang W.F., Lu J.H. High myopia as a risk factor in primary open angle glaucoma. Int J Ophthalmol. 2012;5(6):750-753. https://doi.org/10.3980/j.issn.2222-3959.2012.06.18

15. Kim S.W., Kang G.W. Diabetes mellitus as a risk factor for glaucoma outcome in Korea. Acta Ophthalmol. 2017;95(7):e662-e664. https://doi.org/10.1111/aos.13345

16. Primus S., Harris A., Siesky B.A., Guidoboni G. Diabetes: a risk factor for glaucoma? Br J Ophthalmol. 2011;95(12):1621-1622. https://doi.org/10.1136/bjophthalmol-2011-300788

17. Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238-242. https://doi.org/10.1136/bjo.86.2.238

18. Anderson D.R.; Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14(2):86-90. https://doi.org/10.1097/00055735-200304000-00006

19. Guedes G., Tsai J.C., Loewen N.A. Glaucoma and aging. Curr Aging Sci. 2011;4(2):110-117. https://doi.org/10.2174/1874609811104020110

20. Quigley H.A. Glaucoma. Lancet. 2011;377(9774):1367-1377. https://doi.org/10.1016/S0140-6736(10)61423-7

21. Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. https://doi.org/10.1001/jama.2014.3192

22. Buzrukov B.T., Babadjanova L.D., Buzrukova D.B. Results of biologic marking of primary glaucoma in the Uzbek population in conditions of panmixia. New Day Medicine. 2013;1(1):17-19.

23. Chechenina N.G., Shaposhnikova I.V., Frolova E.A., Lemberg O.V. The main sources of glaucoma detection at outpatient appointments. Permanent Residence. Clinical Ophthalmology. 2008;9(4):119-120. (In Russ.)

24. Aksenova M.A. Analysis of medical and social risk factors for primary open-angle glaucoma. Bulletin of the Voronezh Institute of High Technologies. 2009;4:113-115. (In Russ.)

25. Balalin S.V., Fokin V.V. Risk factors and tolerant intraocular pressure in primary open-angle glaucoma. Bulletin of Orenburg State University. 2013;4(153):32-35. (In Russ.)

26. Kang J.M., Tanna A.P. Glaucoma. Med Clin North Am. 2021;105(3):493-510. https://doi.org/10.1016/j.mcna.2021.01.004

27. Jayaram H., Kolko M., Friedman D.S., Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788-1801. https://doi.org/10.1016/S0140-6736(23)01289-8

28. Sun M.T., Tran M., Singh K., Chang R., Wang H., Sun Y. Glaucoma and myopia: diagnostic challenges. Biomolecules. 2023;13(3):562. https://doi.org/10.3390/biom13030562

29. Tuichibayeva D.M., Yangieva N.R., Agzamova S.S., Abaskhanova N.H. Analysis of public awareness about risk factors, treatment, and prevention of primary glaucoma. Ophthalmology. Eastern Europe. 2024;14(1):33-42. https://doi.org/10.34883/PI.2024.14.1.015 (In Russ.)

30. Kasimov A.K. Determining the risk of developing primary angle-closure glaucoma based on morphological factors. Economics and Society. 2022;8(99):195-199. (In Russ.)

31. Kovalevskaya M.A., Antonyan W.B. Subjective risk factors for glaucoma. New Technologies in Ophthalmology: Proceedings of the Republican Scientific and Practical Conference Dedicated to the 100th Anniversary of the Republican Clinical Ophthalmological Hospital Named After Professor E.V. Adamyuk. 2022; April 15-16, Kazan. Kazan: Publishing House «Medicine»; 2022:86-98. (In Russ.)

32. Avdeev R.V., Alexandrov A.S., Basinsky A.S., et al. Evaluation of clinical and instrumental data on the study of the organ of vision in patients with primary open-angle glaucoma and macular degeneration. Bashkortostan Medical Journal. 2014;9(2):24-28. (In Russ.)

33. Kuroedov A.V., Avdeev R.V., Alexandrov A.S., et al. Primary open-angle glaucoma: at what age of the patient and at what duration of the disease blindness may occur. Medical and Biological Problems of Life Activity. 2014;2(12):74-84. (In Russ.)

34. Kuroedov A.V., Avdeev R.V., Alexandrov A.S., et al. The estimated age of patients and the period of illness for intensive therapeutic and preventive manipulations in primary glaucoma. Ophthalmology. Eastern Europe. 2014;3(22):60-71. (In Russ.)

35. Zagidullina A.S, Aznabaev B.M., Zulkarneev R.H. Factor analysis of the risk of primary open-angle glaucoma. Russian Annals of Ophthalmology. 2022;138(1):23-30. https://doi.org/10.17116/oftalma202213801123 (In Russ.)

36. Agarkov N.M., Chukhraev A.M., Konyaev D.A., Popova E.V. Diagnosis and prediction of the course of primary open-angle glaucoma by the level of local cytokines. Russian Annals of Ophthalmology. 2020;136(4):94-98. https://doi.org/10.17116/oftalma202013604194 (In Russ.)

37. Sakhnov C.H. Organization of early detection of glaucoma and its prognostication considering digital screening of medical social risk factors. J Health Care of the Russian Federation. 2018;62(4):197-200. (In Russ.)

38. Sakhnov S.N., Kharchenko V.V. Diagnosis and prognostication of glaucoma. Russian Clinical Laboratory Diagnostics. 2018;63(4):246-249. (In Russ.)

39. Sakhnov S.N. Computer screening of medical and social risk factors of glaucoma for the organization of its early detection. J Systems Analysis and Management in Biomedical Systems. 2018;17(3):776-781. (In Russ.)

40. Sakhnov S.N., Aksenov V.V. A computer management system for ophthalmological services in the detection of glaucoma and cataracts. Proceedings of the Southwestern State University. Series: IT Management, Computer Science, Computer Engineering. Medical Equipment Engineering. 2018;8(27):91-100. (In Russ.)


Review

For citations:


Bolbachan O.A., Omorova G.K., Bolbachan K.N. Risk Assessment of Glaucoma in the Kyrgyz Republic. City Healthcare. 2025;6(1):66-75. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2025.v.6i1;66-75

Views: 138


ISSN 2713-2617 (Online)